Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

508 public trials 142 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

NCT07101328

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +23 more
Locations
  • City of Hope Duarte, California, United States
  • University of Colorado Denver - School of Medicine - Anschutz Medical Campus Aurora, Colorado, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Yale University School of Medicine - Yale Cancer Center New Haven, Connecticut, United States
View all 51 locations
View Trial Details
Recruiting

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

NCT06393738

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Detroit, Michigan, United States
  • Clinical Trial Site New Brunswick, New Jersey, United States
  • Clinical Trial Site New York, United States
View all 21 locations
View Trial Details
Recruiting

Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma

NCT07652580

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune Dysregulation, +12 more
Locations
  • Uniformed Services University of the Health Sciences Bethesda, Maryland, United States
  • Walter Reed National Military Medical Center Bethesda, Maryland, United States
  • Naval Medical Center Portsmouth Portsmouth, Virginia, United States
View Trial Details
Recruiting

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

NCT07516093

Conditions
B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations
  • Central Georgia Cancer Care Macon, Georgia, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • Hematology Oncology of Indiana Indianapolis, Indiana, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details
Recruiting

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

NCT07520006

Conditions
B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • University of Miami Coral Gables, Florida, United States
  • Oncology Associates of Oregon Eugene, Oregon, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

NCT07123454

Conditions
B-Cell Non-Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations
  • Research Site Irvine, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site New York, United States
View all 23 locations
View Trial Details
Recruiting

A Study of ARC-02 in B-cell NHL

NCT07691606

Conditions
B-cell Non Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations
  • Start Cala Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • NYU Langone New York, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
View all 29 locations
View Trial Details
Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

NCT05826535

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • University of California-Irvine Medical Center Irvine, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Los Angeles (UCLA) Medical Center Los Angeles, California, United States
  • Scripps Clinic San Diego, California, United States
View all 35 locations
View Trial Details
Recruiting

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

NCT07439653

Conditions
Hemic and Lymphatic Diseases, Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma, Immune System Diseases, +8 more
Locations
  • UCLA Santa Monica, California, United States
  • Stanford University Stanford, California, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Providence Medical Foundation Fullerton, California, United States
View Trial Details

Related conditions